FDA grants Darzalex Priority Review for first-line MM

Genmab A/S (CSE:GEN; Pink:GMXAY) said FDA accepted and granted Priority Review to an sBLA from partner Johnson & Johnson (NYSE:JNJ) for

Read the full 216 word article

User Sign In